Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovulation Incidence in Oral Contraceptive Users
NCT03106454Phase 3Completed
- Sponsor
- University of Southern California
- Start
- Aug 2014
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ethinyl estradiol in contraception (2 arms), sponsored by University of Southern California. Primary endpoint: Ovulation Incidence at 28 days. Started Aug 2014; status: completed.
02
Drugs
ethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03106454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03106454.